Astellas Pharma, Inc. (ALPMY)
Astellas Pharma Market Cap : 29.11B for April 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Pfizer Inc. | 154.87B |
| Nxera Pharma Co., Ltd. | 477.81M |
| PeptiDream Inc. | 1.067B |
| Stemcell Holdings, Inc. | 60.00M |
| Healios KK | 310.50M |
Market Cap Related Metrics
| PE Ratio | 13.56 |
| PS Ratio | 2.119 |
| Price to Book Value | 2.588 |
| Price to Free Cash Flow | 11.26 |
| Price | 16.25 |
| Earnings Yield | 7.38% |
| Operating PE Ratio | 10.79 |
| Normalized PE Ratio | 13.56 |